BENZENO SHARON (Sr VP, Drug Discovery) sold 42.8% of their position (165.80K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market

Open‑market sale worth $3.50M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales

BENZENO SHARON

Filed: 6/30/2026ACC: 0001780854-26-000008

InsiderBENZENO SHARONCIK 1780854

→

IssuerADAPTIVE BIOTECHNOLOGIES CORPCIK 1478320

Officer· Sr VP, Drug Discovery

Since Jun 2019

-165.80K

Net shares

Net seller

$3.50M

Total sold

Open market trades

0B · 2S

Total transactions

114.33K acquired · 280.13K disposed

Non-Derivative Transactions7

Common Stock

Direct

M · Option Exercise

+11.03K

Price / share

$12.14

Trade value

$133.95K

% of position

4.0%

6/26/2026

272.75K→283.79K

Common Stock

Direct

S · Sale

−11.03K

Price / share

$21.00

Trade value

$231.71K

% of position

3.9%

6/26/2026

283.79K→272.75K

Common Stock

Direct

M · Option Exercise

+1.84K

Price / share

$12.14

Trade value

$22.30K

% of position

0.7%

6/29/2026

272.75K→274.59K

Common Stock

Direct

M · Option Exercise

+24.94K

Price / share

$8.46

Trade value

$211.03K

% of position

9.1%

6/29/2026

274.59K→299.53K

Common Stock

Direct

M · Option Exercise

+24.94K

Price / share

$3.99

Trade value

$99.53K

% of position

8.3%

6/29/2026

299.53K→324.48K

Common Stock

Direct

M · Option Exercise

+51.57K

Price / share

$8.12

Trade value

$418.75K

% of position

15.9%

6/29/2026

324.48K→376.05K

Common Stock

Direct

S · Sale

−154.77K

Price / share

$21.14

Trade value

$3.27M

% of position

41.2%

6/29/2026

376.05K→221.28K

Total

Net shares

−51.47K

Net value

-$2.62M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	6/26/2026	M · Option Exercise	+11.03K	$12.14	$133.95K	4.0%	272.75K	283.79K
Common Stock Direct	6/26/2026	S · Sale	−11.03K	$21.00	$231.71K	3.9%	283.79K	272.75K
Common Stock Direct	6/29/2026	M · Option Exercise	+1.84K	$12.14	$22.30K	0.7%	272.75K	274.59K
Common Stock Direct	6/29/2026	M · Option Exercise	+24.94K	$8.46	$211.03K	9.1%	274.59K	299.53K
Common Stock Direct	6/29/2026	M · Option Exercise	+24.94K	$3.99	$99.53K	8.3%	299.53K	324.48K
Common Stock Direct	6/29/2026	M · Option Exercise	+51.57K	$8.12	$418.75K	15.9%	324.48K	376.05K
Common Stock Direct	6/29/2026	S · Sale	−154.77K	$21.14	$3.27M	41.2%	376.05K	221.28K
Total			−51.47K		-$2.62M

Derivative Transactions5

Stock Option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

11.03K shares

−11.03K

Strike price

12.14

Held after

1.84K

Exercisable

—

6/26/2026

Stock Option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

1.84K shares

−1.84K

Strike price

12.14

Held after

0.00

Exercisable

—

6/29/2026

Stock Option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

24.94K shares

−24.94K

Strike price

8.46

Held after

37.42K

Exercisable

—

6/29/2026

Stock Option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

24.94K shares

−24.94K

Strike price

3.99

Held after

87.30K

Exercisable

—

6/29/2026

Stock Option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

51.57K shares

−51.57K

Strike price

8.12

Held after

113.46K

Exercisable

—

6/29/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option (right to buy) Direct	Common Stock11.03K shares	6/26/2026	M · Option Exercise	−11.03K	12.14	—	1.84K
Stock Option (right to buy) Direct	Common Stock1.84K shares	6/29/2026	M · Option Exercise	−1.84K	12.14	—	0.00
Stock Option (right to buy) Direct	Common Stock24.94K shares	6/29/2026	M · Option Exercise	−24.94K	8.46	—	37.42K
Stock Option (right to buy) Direct	Common Stock24.94K shares	6/29/2026	M · Option Exercise	−24.94K	3.99	—	87.30K
Stock Option (right to buy) Direct	Common Stock51.57K shares	6/29/2026	M · Option Exercise	−51.57K	8.12	—	113.46K